PHM and MMI supports Lybian Resolution on access to vaccines

In a public statement made on 20th of May, PHM and Medicus Mundi International (MMI) endorsed a resolution presented by Libya, highlighting the urgent need for transparent pricing of vaccines and clearer documentation of price barriers. The resolution recognizes the importance of competition to reduce prices and make vaccines affordable through generic competition.

PHM and MMI are concerned about the pressure on countries to introduce new vaccines in the absence of surveillance and information systems covering epidemiology, delivery, and evidence of safety and efficacy. PHM urged WHO to give increased priority to the development of rigorous post-marketing surveillance systems including adverse events following immunisation.

PHM activists are at the WHA as part of PHM's WHO watch initiative.